Wendy N. Cooper
Cambridge, ENG CB20RE, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Cell-free DNA size deconvolution resolves nucleosomal origins and reveals tumor-associated fragmentomic alterations.
Journal: Nature communications
Published: September 22, 2025
ctDNA monitoring using tumor-informed copy number analysis.
Journal: EMBO molecular medicine
Published: August 05, 2025
A standardized framework for robust fragmentomic feature extraction from cell-free DNA sequencing data.
Journal: Genome biology
Published: September 03, 2024
Overexpression of Igf2-derived Mir483 inhibits Igf1 expression and leads to developmental growth restriction and metabolic dysfunction in mice.
Journal: Cell reports
Published: January 10, 2023
Comparison of tumor-informed and tumor-naïve sequencing assays for ctDNA detection in breast cancer.
Comparison of tumor-informed and tumor-naïve sequencing assays for ctDNA detection in breast cancer.
Journal: EMBO molecular medicine
Published: June 28, 2022
Characteristics, origin, and potential for cancer diagnostics of ultrashort plasma cell-free DNA.
Journal: Genome research
Published: May 03, 2021
Fragmentation patterns and personalized sequencing of cell-free DNA in urine and plasma of glioma patients.
Journal: EMBO molecular medicine
Published: June 04, 2020
Mesenchyme-derived IGF2 is a major paracrine regulator of pancreatic growth and function.
Journal: PLoS genetics
Published: April 29, 2020
ctDNA monitoring using patient-specific sequencing and integration of variant reads.
Journal: Science translational medicine
Published: October 10, 2019
Detection of ctDNA from Dried Blood Spots after DNA Size Selection.
Journal: Clinical chemistry
Published: October 04, 2019
Comprehensive characterization of cell-free tumor DNA in plasma and urine of patients with renal tumors.
Journal: Genome medicine
Published: September 19, 2019
Last Updated: 09/26/2026